SCHEMBL22778043

SCHEMBL22778043

CCNc1cc(N2CCOCC2)ccc1[N+](=O)[O-]

nearest known ligand 0.79

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 15/20 0.79
ALDH1A1 P00352 6/20 0.78
MAPK1 P28482 4/20 0.78
L3MBTL1 Q9Y468 1/20 0.75
LMNA P02545 3/20 0.67
HTT P42858 2/20 0.67
NPSR1 Q6W5P4 1/20 0.67
TDP1 Q9NUW8 2/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
HPGD P15428 1/20 0.65
PKM P14618 2/20 0.61
POLB P06746 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
DCTPP1 Q9H773 3/20 0.61
CYP1A2 P05177 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29484079 0.90 MAPT (0.75) MAPTALDH1A1MAPK1L3MBTL1LMNA
SCHEMBL19286334 0.87 MAPT (0.97) MAPTALDH1A1MAPK1L3MBTL1LMNA
SCHEMBL3614295 0.86 MAPK1 (1.00) MAPTALDH1A1MAPK1L3MBTL1DCTPP1
SCHEMBL3616361 0.85 MAPT (1.00) MAPTALDH1A1MAPK1L3MBTL1HTT
SCHEMBL18036523 0.82 MAPT (0.75) MAPTALDH1A1MAPK1L3MBTL1LMNA
SCHEMBL3616153 0.81 MAPK1 (0.74) MAPTALDH1A1MAPK1L3MBTL1HTT
SCHEMBL3616157 0.81 MAPK1 (0.74) MAPTALDH1A1MAPK1L3MBTL1HTT
SCHEMBL15340797 0.81 MAPT (0.66) MAPTALDH1A1MAPK1L3MBTL1LMNA
SCHEMBL7809558 0.81 MAPT (0.67) MAPTALDH1A1MAPK1LMNAHTT
SCHEMBL25313017 0.80 MAPT (0.64) MAPTALDH1A1MAPK1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250243168-A1 ACETYL-COA SYNTHETASE 2 (ACSS2) INHIBITORS AND METHODS USING SAME THE WISTAR INST (US) 2025-07-31 US disclosed
US-12281084-B2 Acetyl-CoA synthetase 2 (ACSS2) inhibitors and methods using same THE WISTAR INSTITUTE (US) 2025-04-22 US disclosed
US-20220281826-A1 ACETYL-COA SYNTHETASE 2 (ACSS2) INHIBITORS AND METHODS USING SAME THE WISTAR INSTITUTE 2022-09-08 US disclosed
CN-114466840-A acetyl-CoA synthetase 2(ACSS2) inhibitors and methods of use thereof 威斯达研究所 2022-05-10 CN disclosed
EP-3983391-A1 ACETYL-COA SYNTHETASE 2 (ACSS2) INHIBITORS AND METHODS USING SAME The Wistar Institute (US) 2022-04-20 EP disclosed
WO-2020252407-A1 ACETYL-COA SYNTHETASE 2 (ACSS2) INHIBITORS AND METHODS USING SAME THE WISTAR INSTITUTE (US) 2020-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12281084-B2 Acetyl-CoA synthetase 2 (ACSS2) inhibitors and methods using same ACSS2, ACACB, ACACA MAPT 4463/4885ALDH1A1 170/4885MAPK1 4052/4885
US-20220281826-A1 ACETYL-COA SYNTHETASE 2 (ACSS2) INHIBITORS AND METHODS USING SAME ACSS2, ACACB, ACACA MAPT 4463/4885ALDH1A1 170/4885MAPK1 4052/4885
US-20250243168-A1 ACETYL-COA SYNTHETASE 2 (ACSS2) INHIBITORS AND METHODS USING SAME ACSS2, ACACB, ACACA MAPT 4463/4885ALDH1A1 170/4885MAPK1 4052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.